CLINDASEPTIN Włochy - włoski - Ministero della Salute

clindaseptin

chanelle pharmaceuticals manufacturing ltd - clindamicina cloridrato - clindamicina cloridrato - nd - clindamycin

Dapagliflozin Viatris Unia Europejska - włoski - EMA (European Medicines Agency)

dapagliflozin viatris

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - farmaci usati nel diabete - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 e 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Tolvaptan Accord Unia Europejska - włoski - EMA (European Medicines Agency)

tolvaptan accord

accord healthcare s.l.u. - tolvaptan - sindrome adh inappropriata - diuretici, - tolvaptan is indicated in adults for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (siadh).